US Stocks Rally as Omicron Fears Recede

US Stocks Rally as Omicron Fears Recede

Early data showing that the Omicron variant is not as serious as previous strains led to a rush of positive trading on Wall Street this Thursday.

The S&P 500 was close to its record high from late November. Buoyed by positive gains from stocks like MGM Resorts that are sensitive to pandemic news, the bourse gained 0.6%.

After more vaccine manufacturers said their jabs provided protection against Omicron, consistent evidence is emerging from South Africa and the UK that Omicron causes far fewer hospitalizations than previous variants.

Investors are now heading into the new year in much better spirits as Omicron’s effect on global economies is expected to be less severe than once feared. 

Continuing the positive trend, the Dow Jones Industrial Average was up 0.65% at the end of Thursday’s trading. The Nasdaq Composite gained 0.43% over the same period.

What does this mean for me?

This year, news of the pandemic became a bellwether for the global economy. One one hand, unwelcome news, such as increased restrictions, had the effect of immediately dampening market sentiment. On the other hand, as we have seen from this short piece, positive news was received well by the market as investors could look forward to uninterrupted trading.

As a stock trader and market watcher, it pays to understand how important global news shapes market sentiment. The more you can decipher the effects of world events and apply them proactively to your portfolio, the better your trading skills will become.

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.